Chase Therapeutics
Washington
About Chase Therapeutics
Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company focused on the development of better treatments for brain disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $25.3M
- Funding stage: M&A
- Last round: Series B (Oct 2021)
- Website: chasetherapeutics.com
- Phone: (202) 223-7002
Industries & Categories
Medical, Medical Device, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/chase-therapeutics-120578 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.